首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1442903

感染预防与对策 - 全球市场考量、竞争格局、市场预测（2030）

Infection Prevention and Control - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年03月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

预计2024年至2030年期间，全球感染预防及控制市场规模将以6.13%的复合年增长率大幅成长。感染预防和控制的需求主要是由于慢性病患病率不断上升、需要高强度感染预防的外科手术增加、医院感染增加以及政府加强确保先进的感染预防而增长。在医疗行业，不断增加的产品推出、产品开发的技术创新等，正在推动2024-2030年预测期内感染预防和控制市场的整体成长。

感染预防的市场动态及对策

预计全球医院感染的流行将在预测期内加强医院感染预防市场。

例如，根据世界卫生组织 (WHO) (2022) 的数据，估计全世界每年有数亿人受到医疗保健相关感染 (HAI) 的影响，其中许多感染是完全可以避免的。

数据显示，每100名患者中有7名来自高收入国家，15名来自中低收入国家。世界卫生组织也得出结论，在全球范围内，十分之一的受影响患者死于医院感染。

从这些数字中，我们可以得出结论，全世界医院感染的盛行率正在增加。透过保持适当的手部卫生、佩戴口罩和手套等防护装备、对污染区域进行消毒以及对医院使用的所有设备进行适当消毒等不良做法，可以降低因感染而增加的发病率和死亡率。措施。因此，上述因素将推动预测期内感染预防和控制的整体市场成长。

环境污染、吸烟、不健康的生活方式、营养和饮食，包括发炎性肠道疾病（IBD）、胃食道逆流（GERD）、消化性溃疡、克隆氏症、糖尿病、高血压、心血管疾病和癌症。慢性病盛行率上升由于生活方式的紊乱和大量致癌物质的摄入将推动感染预防和控制产品和设备的市场。

例如，根据International Diabetes Federation的《Diabetes Atlas第10版报告》（2021年），2021年全球有5.37亿成年人（20-79岁）患有糖尿病。预计到 2030 年，这一数字将增至 6.43 亿，到 2045 年将增至 7.83 亿。慢性病盛行率的增加也增加了外科手术的数量并增加了感染的风险。透过遵循适当的灭菌和消毒技术以及使用各种感染来预防和控制产品，例如手部和表面消毒剂、手套和口罩，可以阻止传染病。

因此，由于慢性病盛行率上升而导致的外科手术数量的增加可能会增加医院感染的盛行率，从而增加对感染预防和控制产品的需求。

此外，政府机构正在积极发布指导方针，旨在提高全球对有效预防措施的认识，预计这将在预测期内的市场成长中发挥重要作用。例如，世界卫生组织（WHO）发布了卫生行业预防和管理急性呼吸道疾病的指南，这些疾病使人们容易患上流行病和流行病。建议从常识性安全措施（例如经常洗手）到使用个人防护装备以及灭菌和消毒的说明。

因此，上述因素将在2024-2030年预测期内推动感染预防和控制市场。

然而，化学消毒剂的不利影响以及对再加工器械安全性的严格监管要求可能会抑制感染防治市场的整体成长。

感染防治市场细分分析

在感染预防和控制市场的产品类型细分市场中，洗手液类别预计将在2023年获得可观的收入占有率。这可以归因于与该细分市场相关的好处和用途。

洗手液可以在很短的时间内杀死表面上的细菌和病毒。此外，洗手液通常无毒、无刺激、便宜且不会引起过敏。

本报告研究和分析了全球感染预防和控制市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

Infection Prevention And Control Market By Product (Equipment [Sterilization Equipment {Heat Sterilization Equipment, Low-Temperature Sterilization Equipment, Radiation Sterilization, And Others} And Disinfectors {Washers, Flushes, Endoscope Reprocessors, And Others}] And Consumables [Disinfectants {Hand Disinfectants, Surface Disinfectants, Skin Disinfectants, And Others}, Personal Protective Equipment {Surgical Drapes, Surgical Gowns, Gloves, And Others}, Sterilization Consumables, Infectious Waste Disposal, And Others]), End-User (Hospitals & Clinics, Medical Device And Pharmaceutical Companies, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of hospital-acquired infection and growing number of surgical procedures that require high-intensity infection prevention

The global infection prevention and control market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.13% during the forecast period from 2024 to 2030. The demand for infection prevention and control is primarily being boosted by the increasing prevalence of increasing incidence of chronic diseases, the growing number of surgical procedures that require high-intensity infection prevention, growing figures of hospital-acquired infections, the rising number of government initiatives to ensure a high degree of infection prevention, growing healthcare industry, increasing product launches, and innovation in product development among others, thereby contribute to the overall growth of the infection prevention and control market during the forecast period from 2024-2030.

Infection Prevention And Control Market Dynamics:

The increasing prevalence of hospital-acquired infection globally is anticipated to bolster the market for hospital-acquired infection control during the forecasted period.

For instance, according to the World Health Organization (WHO) 2022, it was estimated that globally hundreds of millions of people every year are affected by healthcare-associated infections (HAIs), many of which are completely avoidable.

As per the same source, it was reported that out of every 100 patients, 7 patients are in high- and 15 patients in low or middle-income countries. WHO also concluded that globally, 1 in every 10 affected patients dies of a hospital-acquired infection.

From the above figures, it can be concluded that the prevalence of hospital-acquired infection is increasing globally. The increasing prevalence and mortality from the infection can be controlled by following proper measures such as maintaining proper hand hygiene, wearing masks, gloves, and other protective gear, disinfecting the area subjected to contamination, and following proper sterilization of all the equipment used in the hospitals; thereby increasing the demand of infection prevention and control products across the globe. Thus, the above factor will be responsible in propelling the overall market growth of infection prevention and control during the forecast period.

The rise in prevalence of chronic diseases like inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), peptic ulcer disease, Crohn's disease, diabetes, hypertension, cardiovascular disorders, cancer, and others due to environmental pollution, smoking, unhealthy lifestyles, poor nutrition and diet, and high intake of carcinogenic substances will drive the market of infection prevention and control product and devices.

For instance, according to the International Diabetes Federation, Diabetes Atlas 10th edition report 2021, globally 537 million adults (20-79 years) were living with diabetes in 2021. This number is predicted to rise to 643 million by 2030 and 783 million by 2045. The rising prevalence of chronic disease will also increase the number of surgical procedures which in turn will increase the risk of infections. The transition of infections can be ceased by following proper sterilization and disinfectant techniques and also by using various infection prevention and control products such as hand or surface disinfectant, gloves, masks, and others.

Therefore, the rising number of surgical procedures owing to the rising prevalence of chronic disorders may increase the prevalence of hospital-acquired infections ultimately increasing the demand for infection prevention and control products.

In addition, government agencies are likely to play a larger role in the market's growth throughout the forecast period as they become more active in the issuance of guidelines aimed at raising global awareness of effective preventive measures. For example, the World Health Organization (WHO) has published guidelines for the healthcare industry's prevention and management of acute respiratory disorders that are susceptible to pandemics and epidemics. The recommendations cover anything from common sense safety measures like washing your hands often to using personal protective equipment and instructions for sterilizing and disinfecting.

Therefore, the above-mentioned factors will propel the infection prevention and control market during the forecast period from 2024-2030.

However, adverse effects of chemical disinfectants, stringent regulatory requirements with concerns for the safety of reprocessed instruments, and others may restrict the growth of the overall infection prevention and control market.

Infection Prevention And Control Market Segment Analysis:

Infection Prevention and Control Market by Product (Equipment [Sterilization Equipment {Heat Sterilization Equipment, Low-Temperature Sterilization Equipment, Radiation Sterilization, and Others} and Disinfectors {Washers, Flushes, Endoscope Reprocessors, and Others}] and Consumables [Disinfectants {Hand Disinfectants, Surface Disinfectants, Skin Disinfectants, and Others}, Personal Protective Equipment {Surgical Drapes, Surgical Gowns, Gloves, and Others}, Sterilization Consumables, Infectious Waste Disposal, and Others]), End-User (Hospitals & Clinics, Medical Device And Pharmaceutical Companies, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the infection prevention and control market, the hand disinfectants category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with the segment.

Hand disinfectants take very little time to kill the bacteria or viruses present on any surface. Additionally, hand disinfectants are generally nontoxic, non-irritating, inexpensive, and non-allergenic.

Hand disinfectants are easily portable therefore they can be used anywhere. It not only kills germs but prevents the transmission of germs from one person to another.

Further, alcohol-based hand disinfectants effectively reduce the bacterial counts on hands better than soap and water. Alcohol-based hand disinfectants are more effective against most bacteria and many viruses than either medicated or non-medicated soaps.

In addition, the usage of hand disinfectants was higher in hospitals during the pandemic as the number of hospitalizations increased during this time. The prime aim of hand disinfectants was to provide protection in healthcare facilities and safeguard personnel performing medical procedures that expose them to the virus.

Moreover, the product launches in the local market, in turn, drive the product demand in the market. For instance, in May 2020, Dukes India launched hand sanitizers, a type of hand disinfectant named Hand Safe, to help combat the COVID-19 virus.

Also, in June 2020, Cadila Pharmaceuticals launched a range of hand sanitizers, under the brand name Santiza and Laglo.

Therefore, owing to the above-mentioned factors, the hand disinfectants category is expected to register significant growth, thereby driving the growth of the overall infection prevention and control market during the forecast period.

North America is expected to dominate the overall Infection Prevention And Control Market:

Among all the regions, North America is estimated to account for the largest share of the infection prevention and control market in the year 2023. Owing to the significance of key growth factors such as the growing incidence of chronic diseases such as cancer, kidney disease, Crohn's disease, growing incidence of hospital-acquired infections and the high geriatric population, and high awareness about the advantages of proper infection prevention and control, consistent number of strategic collaborations, growing presence of outsourcing organizations, growing healthcare expenditure, unprecedented evolution of the healthcare standards and infrastructure, and others, the market for infection prevention and control is expected to witness prosperity in the region during the forecast period 2024-2030.

According to the Centers for Disease Control and Prevention (CDC), 2020 Annual National and State Healthcare-Associated Infections (HAI) Progress Report, it was estimated that between 2019 and 2020 in the United States, about 24% increase seen in central line-associated bloodstream infections (CLABSI) with the largest increase in infections transmitted from ICU.

The increasing prevalence of hospital-acquired infections will in turn increase the demand for infection prevention and control devices and consumables in the United States.

Further, a consistent number of strategic collaborations adopted by key market players to widen their product portfolio and infection control capabilities are believed to be responsible for the greater share captured by this region. For instance, In March 2023, Getinge completed the acquisition of Ultra Clean Systems Inc., a leading US manufacturer of ultrasonic cleaning technologies, used in hospitals and surgery centers to decontaminate surgical instruments. Ultrasonic cleaning is an integral part of best practices for reprocessing instruments, especially the most complex ones used for robotic surgery, to minimize the risk of hospital-acquired infections

Also, in March 2019, Getinge announced the US launch of a new 9100E Cart Washer. The 9100E Cart Washer represents the evolution of the company's successful 9100 series floor-loading cart and utensil washer-disinfectors. It was specifically designed to address the needs of hospitals, which require washers that have a reliable and sufficient throughput of a large variety of items that cannot be disinfected in a traditional instrument washer-disinfector, such as operating table transport trolleys, instrument containers, and other bulky items.

Thus, the above-mentioned factors are likely to propel the growth of the infection prevention and control market in the region during the forecast period from 2024-2030.

Infection Prevention And Control Market Key Players:

Some of the key market players operating in the infection prevention and control market include 3M, Fortive, Medivators Inc., Getinge AB, MELAG Medizintechnik GmbH & Co. KG, Metrex Research, LLC, MMM Group, STERIS, Sotera Health LLC, Nanosonics, BD, Owens & Minor, Matachana Group, Xenex Disinfection Services Inc., Ecolab, Bombayengg, Pal International, BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD., Miele Group, Belimed AG, and others.

Recent Developmental Activities in the Infection Prevention And Control Market:

In August 2021, Advanced Sterilization Products, a Fortive company, launched the STERRAD VELOCITY, a biological Indicator (BI)/process challenge device (PCD) in the Asia Pacific region.
In June 2021, Nanosonics announced the launch of Nanosonics AuditPro, a new infection prevention digital product platform.
In June 2021, STERIS plc completed the previously announced acquisition of Cantel Medical, a global provider of infection prevention products and services to endoscopy, dental, dialysis, and life sciences Customers.

Key Takeaways from the Infection Prevention And Control Market Report Study

Market size analysis for current infection prevention and control market size (2023), and market forecast for 6 years (2024-2030)
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global infection prevention and control market.
Various opportunities available for the other competitors in the infection prevention and control market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current infection prevention and control market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for infection prevention and control market growth in the coming future?

Target Audience who can be benefited from this Infection Prevention And Control Market Report Study

Infection prevention and control product providers
Research organizations and consulting companies
Infection prevention and control-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in infection prevention and control
Various End-users who want to know more about the infection prevention and control market and the latest technological developments in the infection prevention and control market.

Frequently Asked Questions for the Infection Prevention And Control Market:

1. What is infection prevention and control?

Infection control products are concerned with the prevention or control of infection in healthcare settings, such as laboratories, hospitals, and others.

2. What is the market for global infection prevention and control?

3. What are the drivers for the global infection prevention and control market?

The demand for infection prevention and control is primarily being boosted by the increasing incidence of hospital-acquired infections, the growing number of surgical procedures that require high-intensity infection prevention, the increasing incidence of chronic diseases along with the increasing geriatric population, increasing product launches, and others thereby contributing to the overall growth of the infection prevention and control market during the forecast period from 2024-2030.

4. Who are the key players operating in the global infection prevention and control market?

5. Which region has the highest share in the infection prevention and control market?

North America is expected to dominate the overall infection prevention and control market during the forecast period from 2024-2030. Owing to factors such as the growing incidence of chronic diseases such as cancer, kidney disease, and Crohn's disease, the growing incidence of hospital-acquired infections and the high geriatric population, and high awareness about the advantages of proper infection prevention and control, a consistent number of strategic collaborations, growing presence of outsourcing organizations, growing healthcare expenditure, and unprecedented evolution of the healthcare standards and infrastructure, among others, the North America infection prevention and control market is expected to growth in coming years.

1. Infection Prevention and Control Market Report Introduction

2. Infection Prevention and Control Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Infection Prevention and Control Market Key Factors Analysis

4.1. Infection Prevention and Control Market Drivers
- 4.1.1. Increasing incidence of hospital-acquired infections
- 4.1.2. Growing number of surgical procedures that require high-intensity infection prevention
- 4.1.3. Increasing incidence of chronic diseases along with increasing geriatric population
4.2. Infection Prevention and Control Market Restraints and Challenges
- 4.2.1. Adverse effects of chemical disinfectants
- 4.2.2. Stringent regulatory requirements along with concerns for the safety of reprocessed instruments
4.3. Infection Prevention and Control Market Opportunities
- 4.3.1. Increasing outsourcing of sterilization services
- 4.3.2. Increasing adoption of disinfectant robots

5. Infection Prevention and Control Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. Infection Prevention and Control Market Layout

6.1. By Product
- 6.1.1. Equipment
  - 6.1.1.1. Sterilization Equipment
  - 6.1.1.1.1. Heat Sterilization Equipment
  - 6.1.1.1.2. Low-Temperature Sterilization Equipment
  - 6.1.1.1.3. Radiation Sterilization
  - 6.1.1.1.4. Other Products
  - 6.1.1.2. Disinfectors
  - 6.1.1.2.1. Washers
  - 6.1.1.2.2. Flushes
  - 6.1.1.2.3. Endoscope Reprocessors
  - 6.1.1.2.4. Others
- 6.1.2. Consumables
  - 6.1.2.1. Disinfectants
  - 6.1.2.1.1. Hand Disinfectants
  - 6.1.2.1.2. Surface Disinfectants
  - 6.1.2.1.3. Skin Disinfectants
  - 6.1.2.1.4. Others
  - 6.1.2.2. Personal Protective Equipment
  - 6.1.2.2.1. Surgical Drapes
  - 6.1.2.2.2. Surgical Gowns
  - 6.1.2.2.3. Gloves
  - 6.1.2.2.4. Others
  - 6.1.2.3. Sterilization Consumables
  - 6.1.2.4. Infectious Waste Disposal
  - 6.1.2.5. Others
6.2. By End-User
- 6.2.1. Hospitals & Clinics
- 6.2.2. Medical Device and Pharmaceutical Companies
- 6.2.3. Others
6.3. By Geography
- 6.3.1. North America
  - 6.3.1.1. United States Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.1.2. Canada Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.1.3. Mexico Infection Prevention and Control Market Size in USD million (2021-2030)
- 6.3.2. Europe
  - 6.3.2.1. France Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.2.2. Germany Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.2.3. United Kingdom Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.2.4. Italy Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.2.5. Spain Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.2.6. Rest of Europe Infection Prevention and Control Market Size in USD million (2021-2030)
- 6.3.3. Asia-Pacific
  - 6.3.3.1. China Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.3.2. Japan Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.3.3. India Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.3.4. Australia Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.3.5. South Korea Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.3.6. Rest of Asia-Pacific Infection Prevention and Control Market Size in USD million (2021-2030)
- 6.3.4. Rest of the World (RoW)
  - 6.3.4.1. Middle East Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.4.2. Africa Infection Prevention and Control Market Size in USD million (2021-2030)
  - 6.3.4.3. South America Infection Prevention and Control Market Size in USD million (2021-2030)

7. Infection Prevention and Control Market Company and Product Profiles

7.1. 3M
- 7.1.1. Company Overview
- 7.1.2. Company Snapshot
- 7.1.3. Financial Overview
- 7.1.4. Product Listing
- 7.1.5. Entropy
7.2. Fortive
- 7.2.1. Company Overview
- 7.2.2. Company Snapshot
- 7.2.3. Financial Overview
- 7.2.4. Product Listing
- 7.2.5. Entropy
7.3. Medivators Inc
- 7.3.1. Company Overview
- 7.3.2. Company Snapshot
- 7.3.3. Financial Overview
- 7.3.4. Product Listing
- 7.3.5. Entropy
7.4. Getinge AB
- 7.4.1. Company Overview
- 7.4.2. Company Snapshot
- 7.4.3. Financial Overview
- 7.4.4. Product Listing
- 7.4.5. Entropy
7.5. MELAG Medizintechnik GmbH & Co. KG
- 7.5.1. Company Overview
- 7.5.2. Company Snapshot
- 7.5.3. Financial Overview
- 7.5.4. Product Listing
- 7.5.5. Entropy
7.6. Metrex Research, LLC
- 7.6.1. Company Overview
- 7.6.2. Company Snapshot
- 7.6.3. Financial Overview
- 7.6.4. Product Listing
- 7.6.5. Entropy
7.7. MMM Group
- 7.7.1. Company Overview
- 7.7.2. Company Snapshot
- 7.7.3. Financial Overview
- 7.7.4. Product Listing
- 7.7.5. Entropy
7.8. STERIS
- 7.8.1. Company Overview
- 7.8.2. Company Snapshot
- 7.8.3. Financial Overview
- 7.8.4. Product Listing
- 7.8.5. Entropy
7.9. Sotera Health LLC
- 7.9.1. Company Overview
- 7.9.2. Company Snapshot
- 7.9.3. Financial Overview
- 7.9.4. Product Listing
- 7.9.5. Entropy
7.10. Nanosonics
- 7.10.1. Company Overview
- 7.10.2. Company Snapshot
- 7.10.3. Financial Overview
- 7.10.4. Product Listing
- 7.10.5. Entropy
7.11. BD
- 7.11.1. Company Overview
- 7.11.2. Company Snapshot
- 7.11.3. Financial Overview
- 7.11.4. Product Listing
- 7.11.5. Entropy
7.12. Owens & Minor
- 7.12.1. Company Overview
- 7.12.2. Company Snapshot
- 7.12.3. Financial Overview
- 7.12.4. Product Listing
- 7.12.5. Entropy
7.13. Matachana Group
- 7.13.1. Company Overview
- 7.13.2. Company Snapshot
- 7.13.3. Financial Overview
- 7.13.4. Product Listing
- 7.13.5. Entropy
7.14. Xenex Disinfection Services Inc.
- 7.14.1. Company Overview
- 7.14.2. Company Snapshot
- 7.14.3. Financial Overview
- 7.14.4. Product Listing
- 7.14.5. Entropy
7.15. Ecolab
- 7.15.1. Company Overview
- 7.15.2. Company Snapshot
- 7.15.3. Financial Overview
- 7.15.4. Product Listing
- 7.15.5. Entropy
7.16. bombayengg
- 7.16.1. Company Overview
- 7.16.2. Company Snapshot
- 7.16.3. Financial Overview
- 7.16.4. Product Listing
- 7.16.5. Entropy
7.17. Pal International
- 7.17.1. Company Overview
- 7.17.2. Company Snapshot
- 7.17.3. Financial Overview
- 7.17.4. Product Listing
- 7.17.5. Entropy
7.18. BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD.
- 7.18.1. Company Overview
- 7.18.2. Company Snapshot
- 7.18.3. Financial Overview
- 7.18.4. Product Listing
- 7.18.5. Entropy
7.19. Miele Group
- 7.19.1. Company Overview
- 7.19.2. Company Snapshot
- 7.19.3. Financial Overview
- 7.19.4. Product Listing
- 7.19.5. Entropy
7.20. Belimed AG
- 7.20.1. Company Overview
- 7.20.2. Company Snapshot
- 7.20.3. Financial Overview
- 7.20.4. Product Listing
- 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

简介目录图表

List of Tables

Table 1: Competitive Analysis
Table 2: Infection Prevention and Control Market in Global (2021-2030)
Table 3: Infection Prevention and Control Market in Global by Product (2021-2030)
Table 4: Infection Prevention and Control Market in Global by End-User (2021-2030)
Table 5: Infection Prevention and Control Market in Global by Geography (2021-2030)
Table 6: Infection Prevention and Control Market in North America (2021-2030)
Table 7: Infection Prevention and Control Market in the US (2021-2030)
Table 8: Infection Prevention and Control Market in Canada (2021-2030)
Table 9: Infection Prevention and Control Market in Mexico (2021-2030)
Table 10: Infection Prevention and Control Market in Europe (2021-2030)
Table 11: Infection Prevention and Control Market in France (2021-2030)
Table 12: Infection Prevention and Control Market in Germany (2021-2030)
Table 13: Infection Prevention and Control Market in the United Kingdom (2021-2030)
Table 14: Infection Prevention and Control Market in Italy (2021-2030)
Table 15: Infection Prevention and Control Market in Spain (2021-2030)
Table 16: Infection Prevention and Control Market in the Rest of Europe (2021-2030)
Table 17: Infection Prevention and Control Market in Asia-Pacific (2021-2030)
Table 18: Infection Prevention and Control Market in China (2021-2030)
Table 19: Infection Prevention and Control Market in Japan (2021-2030)
Table 20: Infection Prevention and Control Market in India (2021-2030)
Table 21: Infection Prevention and Control Market in Australia (2021-2030)
Table 22: Infection Prevention and Control Market in South Korea (2021-2030)
Table 23: Infection Prevention and Control Market in Rest of Asia-Pacific (2021-2030)
Table 24: Infection Prevention and Control Market in the Rest of the World (2021-2030)
Table 25: Infection Prevention and Control Market in the Middle East (2021-2030)
Table 26: Infection Prevention and Control Market in Africa (2021-2030)
Table 27: Infection Prevention and Control Market in South America (2021-2030)

List of Figures

Figure 1: Competitive Analysis
Figure 2: Infection Prevention and Control Market in Global (2021-2030)
Figure 3: Infection Prevention and Control Market in Global by Product (2021-2030)
Figure 4: Infection Prevention and Control Market in Global by End-User (2021-2030)
Figure 5: Infection Prevention and Control Market in Global by Geography (2021-2030)
Figure 6: Infection Prevention and Control Market in North America (2021-2030)
Figure 7: Infection Prevention and Control Market in the US (2021-2030)
Figure 8: Infection Prevention and Control Market in Canada (2021-2030)
Figure 9: Infection Prevention and Control Market in Mexico (2021-2030)
Figure 10: Infection Prevention and Control Market in Europe (2021-2030)
Figure 11: Infection Prevention and Control Market in France (2021-2030)
Figure 12: Infection Prevention and Control Market in Germany (2021-2030)
Figure 13: Infection Prevention and Control Market in the United Kingdom (2021-2030)
Figure 14: Infection Prevention and Control Market in Italy (2021-2030)
Figure 15: Infection Prevention and Control Market in Spain (2021-2030)
Figure 16: Infection Prevention and Control Market in the Rest of Europe (2021-2030)
Figure 17: Infection Prevention and Control Market in Asia-Pacific (2021-2030)
Figure 18: Infection Prevention and Control Market in China (2021-2030)
Figure 19: Infection Prevention and Control Market in Japan (2021-2030)
Figure 20: Infection Prevention and Control Market in India (2021-2030)
Figure 21: Infection Prevention and Control Market in Australia (2021-2030)
Figure 22: Infection Prevention and Control Market in South Korea (2021-2030)
Figure 23: Infection Prevention and Control Market in Rest of Asia-Pacific (2021-2030)
Figure 24: Infection Prevention and Control Market in the Rest of the World (2021-2030)
Figure 25: Infection Prevention and Control Market in the Middle East (2021-2030)
Figure 26: Infection Prevention and Control Market in Africa (2021-2030)
Figure 27: Infection Prevention and Control Market in South America (2021-2030)
Figure 28: Market Drivers
Figure 29: Market Barriers
Figure 30: Marker Opportunities
Figure 31: PORTER'S Five Force Analysis

02-2729-4219

+886-2-2729-4219

License/价格

感染预防与对策 - 全球市场考量、竞争格局、市场预测（2030）

Infection Prevention and Control - Market Insights, Competitive Landscape, and Market Forecast - 2030

目录

第一章感染预防与对策市场报告简介

第二章感染预防与对策市场概要

第三章监管分析

第四章感染防治市场主要因素分析

第五章感染防治市场波特五力分析

第六章感染防治市场布局

第七章感染防治市场企业及产品概况

第8章 KOL观点

第9章专案方法

第10章 DelveInsight服务内容

第 11 章关于 DelveInsight

第 12 章免责声明，联络我们

1. What is infection prevention and control?

2. What is the market for global infection prevention and control?

3. What are the drivers for the global infection prevention and control market?

4. Who are the key players operating in the global infection prevention and control market?

5. Which region has the highest share in the infection prevention and control market?